CureBay Secures $21 Million to Expand Rural Healthcare Access in India

Image Courtesy: CureBay website

Odisha-based health-tech startup CureBay has raised $21 million in a funding round led by Bertelsmann India Investments, with participation from British International Investment (BII) and existing investor Elevar Equity. (@EconomicTimes)

🌐 Bridging the Healthcare Gap in Rural India

Founded in 2021, CureBay operates a tech-first hybrid healthcare platform aimed at providing affordable and accessible healthcare services to rural populations. Currently, the company manages over 150 e-clinics across Odisha and Chhattisgarh, staffed by pharmacists and nurses equipped with essential medical devices and point-of-care testing facilities.(@EconomicTimes)

🚀 Strategic Utilization of Funds

The newly acquired capital will be utilized to:

  • Enhance CureBay’s proprietary technology stack, integrating artificial intelligence (AI) and data analytics for predictive care.(@EconomicTimes)
  • Expand operations into additional states, including Jharkhand, Bihar, Uttar Pradesh, and Madhya Pradesh.
  • Recruit and build specialized teams to drive the next phase of growth.

“With an active network of 150+ e-clinics and 1,000+ Swasthya Mitras, we are addressing the healthcare needs of ‘Bharat,’ where a significant portion of the population still lacks access to dependable care,” said Priyadarshi Mohapatra, founder and CEO of CureBay. “This capital will help us scale technology, talent, and reach to bring dignified, affordable healthcare to the last mile.”(@EconomicTimes)

📈 Sustainable and Scalable Model

CureBay’s e-clinics are designed to be asset-light, requiring approximately ₹8.5 lakh to establish each clinic. A cluster of 50 clinics is projected to achieve break-even within 18–20 months, demonstrating the scalability and sustainability of the model.

Source: The Economic Times

Stay Informed – Get the Daily Health & Innovation Updates from ZYAEL Talks Straight to Your Inbox

We don’t spam! Read our privacy policy for more info.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top